Search Within

Martin Stuart Tallman

Formats
  1. Journal Article (323)
  2. Meeting Abstract (280)
  3. Review (19)
  4. Editorial (10)
  5. Book Section (8)
  6. Research Letter (8)
  7. Guidelines (6)
  8. Correspondence (1)
Groups
  1. Adult Leukemia (655)
  2. Center for Hematologic Malignancies (655)
  3. Department of Medicine (655)
  4. Hematologic Malignancies, Division of (655)
  5. GSK Faculty (164)
  6. Executive Committee, Center for Hematologic Malignancies (156)

More Groups

People
  1. Ross Levine (131)
  2. Eytan Stein (118)
  3. Jae Park (81)
  4. Omar Abdel-Wahab (68)
  5. Sean Devlin (65)
  6. Dan Douer (50)

More People

Years
  1. 2025 (6)
  2. 2024 (10)
  3. 2023 (10)
  4. 2022 (26)
  5. 2021 (45)
  6. 2020 (51)

More Years

Publications
  1. Blood (274)
  2. Journal of Clinical Oncology (41)
  3. Blood Advances (27)
  4. Leukemia Research (27)
  5. Leukemia and Lymphoma (26)
  6. Haematologica (25)

More Publications

Publishers
  1. American Society of Hematology (301)
  2. Elsevier Inc. (44)
  3. American Society of Clinical Oncology (41)
  4. Nature Publishing Group (38)
  5. Taylor & Francis Group (28)
  6. Elsevier Ltd (27)

More Publishers

Results (655)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
    Review

    Grever, M.; Andritsos, L.; Banerji, V.; Barrientos, J. C.; Bhat, S.; Blachly, J. S.; Call, T.; Cross, M.; Dearden, C.; Demeter, J.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia
    Journal Article

    Wiernik, P. H.; Sun, Z.; Cripe, L. D.; Rowe, J. M.; Fernandez, H. F.; Luger, S. M.; Lazarus, H. M.; Paietta, E. M.; Tallman, M. S.; Litzow, M. R.
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Interferon alpha therapy in essential thrombocythemia and polycythemia vera — A systematic review and meta-analysis
    Journal Article

    Bewersdorf, J. P.; Giri, S.; Wang, R.; Podoltsev, N.; Williams, R. T.; Tallman, M. S.; Rampal, R. K.; Zeidan, A. M.; Stahl, M.
    Leukemia (2021)

    Fulltext@MSK | Save
  • Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: A phase 1 study
    Journal Article

    Stein, E. M.; DiNardo, C. D.; Fathi, A. T.; Mims, A. S.; Pratz, K. W.; Savona, M. R.; Stein, A. S.; Stone, R. M.; Winer, E. S.; Seet, C. S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia
    Journal Article

    Xiao, W.; Chan, A.; Waarts, M. R.; Mishra, T.; Liu, Y.; Cai, S. F.; Yao, J.; Gao, Q.; Bowman, R. L.; Koche, R. P.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Incorporation of novel therapies for the treatment of acute myeloid leukemia: A perspective
    Review

    Waksal, J. A.; Tallman, M. S.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study
    Journal Article

    Borthakur, G.; Ofran, Y.; Tallman, M. S.; Foran, J.; Uy, G. L.; DiPersio, J. F.; Showel, M. M.; Shimoni, A.; Nagler, A.; Rowe, J. M.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
    Research Letter

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy
    Journal Article

    Glass, J. L.; Derkach, A.; Hilden, P.; King, A.; Seo, S. K.; Ahr, K.; Kishtagari, A.; Levine, R. L.; Tallman, M. S.; Douer, D.
    Leukemia Research (2021)

    Fulltext@MSK | Save
  • Lenalidomide-epoetin alfa versus lenalidomide monotherapy in myelodysplastic syndromes refractory to recombinant erythropoietin
    Journal Article

    List, A. F.; Sun, Z.; Verma, A.; Bennett, J. M.; Komrokji, R. S.; McGraw, K.; Maciejewski, J.; Altman, J. K.; Cheema, P. S.; Claxton, D. F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save